Clinical Trials Logo

Skin Burn Degree Second clinical trials

View clinical trials related to Skin Burn Degree Second.

Filter by:
  • None
  • Page 1

NCT ID: NCT02104713 Completed - Clinical trials for Skin Burn Degree Second

Stem Cell Therapy to Improve Burn Wound Healing

Start date: June 4, 2014
Phase: Phase 1
Study type: Interventional

This study will determine the safety of allogeneic stem cell therapy from healthy donors, for 2nd degree burn wounds of less than 20% Total Body Surface Area (TBSA), at four different dose levels. Clinical evaluation will take place every 1 to 4 weeks intervals until wound closure, and then monthly for 6 months following the last administration of MSCs. Once the safety and dose-response analysis in Phase 1 is completed, an expanded trial will be initiated to better examine the efficacy of MSC therapy in 2nd degree burn wounds. Phase 1 will establish the maximum safe dose that will be used in the Phase II trial.

NCT ID: NCT01790763 Withdrawn - Clinical trials for Skin Burn Degree Second

Compare the Efficacy of Mepilex and Keramatrix in Second Degree Burn Wounds

Start date: April 2015
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine the extent to which Keramatrix dressing promotes the healing of second-degree burn wounds in pediatric patients.